Differential effects of scopolamine on in vivo binding of dopamine transporter and vesicular monoamine transporter radioligands in rat brain
- 1 August 2004
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 188 (2) , 387-390
Abstract
No abstract availableKeywords
Funding Information
- U.S. Department of Energy
- Office of Science
- National Institutes of Health (MH47611)
- Biological and Environmental Research
This publication has 22 references indexed in Scilit:
- Long-term reproducibility of in vivo measures of specific binding of radioligands in rat brainNuclear Medicine and Biology, 2004
- Treatment effects on nigrostriatal projection integrity in partial 6-OHDA lesions: comparison of l -DOPA and pramipexoleExperimental Neurology, 2003
- Slowing Parkinson’s disease progressionNeurology, 2003
- Initial agonist treatment of Parkinson diseaseNeurology, 2003
- Protein kinase C‐mediated translocation of secretory vesicles to plasma membrane and enhancement of neurotransmitter release from PC12 cellsEuropean Journal of Neuroscience, 2002
- Influence of l -dopa and pramipexole on striatal dopamine transporter in early PDNeurology, 2001
- Dopamine Transporter in vitro Binding and in vivo Imaging in the BrainBasic & Clinical Pharmacology & Toxicology, 2001
- Presynaptic monoaminergic vesicles in Parkinson's disease and normal agingAnnals of Neurology, 1996
- Effects of dopaminergic drug treatments on in vivo radioligand binding to brain vesicular monoamine transportersNuclear Medicine and Biology, 1996
- Positron emission tomography (PET) studies of dopaminergic/cholinergic interaction in the baboon brainSynapse, 1990